17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model
about
Preeclampsia: long-term consequences for vascular healthMultimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSFPreeclampsia and Pregnancy-Related Hypertensive DisordersVitamin D supplementation improves pathophysiology in a rat model of preeclampsiaMechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.Identifying immune mechanisms mediating the hypertension during preeclampsiaSevere pre-eclampsia is associated with alterations in cytotrophoblasts of the smooth chorion.Inventory of Novel Animal Models Addressing Etiology of Preeclampsia in the Development of New Therapeutic/Intervention Opportunities.Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy.Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.Linking autoimmunity to the origin of the adaptive immune system.Cardiac myeloperoxidase activity is elevated in hypertensive pregnant rats.
P2860
Q26800272-9AD87633-20C4-4F19-9ABD-101A1320EDF1Q30830726-ECFAEEDF-9C4E-4EBC-9A74-F776C52DCEFCQ36584747-F25CF8D0-B6F7-47FB-9C97-FD9A1FBF332CQ36699839-EA4081F2-20BA-41D7-AF5A-1DC06E724DB1Q37136212-88392A88-8CB3-4D16-9F4C-D76C82647443Q37139722-2BCA242C-448A-41A0-A323-8A8733949BCDQ37731214-7E423356-1EF7-46A1-AAF5-1D6DE06B4D46Q38674096-BB590E40-51BB-45C3-96F2-6989CD0D51B8Q38691672-B5AB5850-08A5-4D56-87CE-995F687AD102Q45350029-EC479E02-9495-4BDE-9422-31F7B2E21B5CQ46342648-0D52BC3E-3DB0-4E28-B779-748A758E1502Q47688833-EDACB6B7-1527-4BEA-9F0A-2C944CE45B2CQ49164628-61B0637F-D7B5-4169-9E4A-A6EF4E05788FQ54132651-072FFE88-B45E-4123-BA4B-A1680FADC7C9
P2860
17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@ast
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@en
type
label
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@ast
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@en
prefLabel
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@ast
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@en
P2093
P2860
P1433
P1476
17-hydroxyprogesterone caproat ...... e perfusion pressure rat model
@en
P2093
Ashlyn Harmon
Babbette LaMarca
Denise C Cornelius
James N Martin
Janae Moseley
Lorena M Amaral
P2860
P304
P356
10.1161/HYPERTENSIONAHA.114.04484
P407
P577
2014-11-03T00:00:00Z